EE457 Long-Term Cost Effectiveness of Mavacamten for Treatment of Hypertrophic Obstructive Cardiomyopathy (HOCM)
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.705
https://www.valueinhealthjournal.com/article/S1098-3015(22)00906-8/fulltext
Title :
EE457 Long-Term Cost Effectiveness of Mavacamten for Treatment of Hypertrophic Obstructive Cardiomyopathy (HOCM)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00906-8&doi=10.1016/j.jval.2022.04.705
First page :
Section Title :
Open access? :
No
Section Order :
10633